Core Laboratories enable discoveries to expand prediction, diagnosis and treatment of disease.

LMM bridges research and clinical medicine, translating novel discoveries into genetic tests and accelerating personalized medicine by using new molecular tests in patient care.

The sixth annual conference will take place November 17-18, 2010 and will explore the opportunities to make Personalized Medicine a reality.

PCPGM IT drives the systems and infrastructure that supports research and clinical operations. We also integrate clinical test results into EMR systems with clinical decision support.

PCPGM supports the Clinical Genetics Residencies and Clinical Laboratory Fellowships that are accredited by the American College of Graduate Medical Education and the American Board of Medical Genetics. Training occurs at Brigham and Women's Hospital, Children's Hospital Boston, and Massachusetts General Hospital.
The Partners Biorepository for Medical Discovery (PBMD) aims to foster collaborations among investigators, physicians and patients seen at Partners HealthCare institutions. This Partners-wide project has been at the forefront of developing the tools needed to expedite the discovery and introduction of new ways to fight disease.
Personalized medicine is the ability to determine an individual's unique molecular characteristics and to use those genetic distinctions to diagnose more finely an individual's disease, select treatments that increase the chances of a successful outcome and reduce possible adverse reactions.